Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Seeger

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer GroupK K Matthay, R C Seeger, C P Reynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
Oncogene|September 22, 1999
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasC Guo, P S White, M J Weiss, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group studyK K Matthay, C Perez, R C Seeger, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
Residential pesticide exposure and neuroblastomaJ L Daniels, A F Olshan, K Teschke, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer GroupK K Matthay, R C Seeger, C P Reynolds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
Oncogene|September 22, 1999
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasC Guo, P S White, M J Weiss, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group studyK K Matthay, C Perez, R C Seeger, et al.
The New England Journal of Medicine|October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer GroupK K Matthay, J G Villablanca, R C Seeger, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalS G DuBois, Y Kalika, J N Lukens, et al.
Medical and Pediatric Oncology|July 24, 2001
Loss of heterozygosity for chromosome 14q in neuroblastomaP M Thompson, B A Seifried, S K Kyemba, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
Residential pesticide exposure and neuroblastomaJ L Daniels, A F Olshan, K Teschke, et al.
Pageof 16